本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Virax Biolabs Group Limited

0.6086
-0.0065-1.06%
盘后0.62860.0200+3.29%19:41 EDT
成交量:15.19万
成交额:9.26万
市值:264.25万
市盈率:-0.37
高:0.6251
开:0.6000
低:0.6000
收:0.6151
52周最高:3.62
52周最低:0.5202
股本:434.20万
流通股本:367.60万
量比:0.51
换手率:4.13%
股息:- -
股息率:- -
每股收益(TTM):-1.6248
每股收益(LYR):-1.6248
净资产收益率:-114.47%
总资产收益率:-64.68%
市净率:0.46
市盈率(LYR):-0.37

数据加载中...

2025/07/02

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/21

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/13

SEC问询函

Form CORRESP - Correspondence
2023/06/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/28

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/22

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/11/29

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/21

招股说明书

F-1 - Registration statement for certain foreign private issuers
2022/08/12

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/07/01

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/30

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/27

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/06/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/24

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers